CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (15,571)	$ (24,122)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation, amortization, and accretion	7,255	4,730
Impairment loss	0	1,585
Provision for bad debts	830	805
Provision for obsolete inventory	597	845
Equity based compensation	2,706	1,039
Change in fair value of contingent consideration	0	(450)
Deferred income tax	(4,002)	13,809
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(15,640)	3,053
Inventories	1,864	(1,836)
Other current assets	(1,004)	958
Other assets	436	(197)
Accounts payable	3,741	(1,688)
Accrued expenses	4,241	(3,274)
Customer deposits	1,243	1,349
Other long-term liabilities	(2,825)	(455)
Net cash used in operating activities	(16,129)	(3,849)
Cash flows from investing activities:
Acquisitions, net of cash acquired	(19,835)	0
Capital expenditures	(2,462)	(3,948)
Capitalization of software costs	(4,068)	(3,892)
Proceeds from sale of business	2,482	1,126
Net cash used in provided by investing activities	(23,883)	(6,714)
Cash flows from financing activities:
Payments of long-term debt	0	(380)
Payment of contingent consideration for Brink Earn Out	(2,550)	0
Payments on bank borrowing	(17,459)	(50,470)
Proceeds on bank borrowing	9,640	57,339
Proceeds from notes payable, net of issuance costs	75,039	0
Proceeds from stock awards	1,433	860
Treasury stock acquired from employees	(544)	0
Net cash provided by financing activities	65,559	7,349
Effect of exchange rate changes on cash and cash equivalents	(996)	99
Net increase (decrease) in cash and cash equivalents	24,551	(3,115)
Cash and cash equivalents at beginning of period	3,485	6,600
Cash and cash equivalents at end of period	28,036	3,485
Cash paid during the period for:
Interest	1,293	308
Income taxes, net of refunds	(321)	285
Non-cash investing and financing:
Notes payable for AccSys	2,000	0
Common stock to be issued for AccSys	27,527	0
Contingent consideration for AccSys	$ 3,340	$ 0